2010 BIOCOM Board of Directors

Chair:

Dan Bradbury, Amylin Pharmaceuticals

Vice Chair:

M. Wainwright Fishburn, Jr., Cooley Godward Kronish LLP

Chair Elect:

Alex Lukianov, Nuvasive

Emeritus:

Randall E. Woods, Sequel Pharmaceuticals

Vice President and General Counsel:

Stephen Ferruolo, J.D., Ph.D., Goodwin Procter LLP

Vice President – Finance:

Theresa Drew, Deloitte

Vice President and Secretary:

Kennon W. Baldwin, Ferguson Pape Baldwin Architects

Vice President – Industry:

David Webb, Ph.D., Celgene

President and CEO:

Joseph D. Panetta, BIOCOM

Executive Committee:

Bernd Brust, Life Technologies
Scott Huennekens, Volcano Corporation
Jack Lief, Arena Pharmaceuticals, Inc.
David Marino, Irving Hughes
Magda Marquet, Ph.D., AltheaDx
Steven J. Mento, Ph.D., Conatus Pharmaceuticals, Inc.
Tina Nova, Genoptix
Trindl Reeves, Barney & Barney LLC
Larry Stambaugh, Apercu Consulting
Kleanthis G. Xanthopoulos, Ph.D., Regulus Therapeutics
Tony Yost, Novartis

Life Directors:

David Hale, Somaxon Pharmaceuticals
William Rastetter, Venrock Associates
Duane J. Roth, CONNECT

Life Sciences Industry Sector:

Vince Anido, Ph.D., ISTA Pharmaceuticals
Martin Birkhofer, Bristol-Myers Squibb R&D
Terrance J. Bruggeman, Geneve Bio, Inc.
Daniel Burgess, Mpex Pharmaceuticals, Inc.
John M. Dunn, Biogen Idec, Inc.
Steven B. Engle, Xoma LLC
Mary Fisher, SkinMedica, Inc.
Kieran Gallahue, ResMed, Inc.
Richard Henson, Source Scientific, Inc.
Carl Hull, Gen-Probe, Inc.
Michael Kamdar, VentiRx Pharmaceuticals
Catherine Mackey, Ph.D., Pfizer La Jolla
Scott Salka, Ambit Biosciences
James Schaeffer, Ph.D., Merck Research Laboratories
Christophe Schilling, Genomatica, Inc.
James Schoeneck, BrainCells, Inc.
Theodore Schroeder, Cadence Pharmaceuticals
Timothy Scott, Pharmatek Laboratories, Inc.
Roger Stoll, Ph.D., Cortex Pharmaceuticals

Associate and Academic Members Sector:

Susan Bryant, Ph.D., UC Irvine
David Brenner, M.D. UCSD Health Sciences
Carin Canale Theakston, Porter Novelli Life Sciences
Larry Cohn, Stradling Yocca Carlson & Rauth
Jack Florio, Brinson Patrick
Scott Foote, Square 1 Bank
Milton Gordon, Ph.D., California State University, Fullerton
Jeffrey W. Guise, Ph.D., Wilson, Sonsini, Goodrich & Rosati
Lisa A. Haile, J.D., Ph.D., DLA Piper
Guy J. Iannuzzi, Mentus, Inc.
Brent D. Jacobs, Cushman & Wakefield
Richard Kaufman, Foley & Lardner LLP
Daniel Kleeburg, Ernst & Young
Susan Nowakowski, AMN Healthcare Services
John C. Reed, M.D., Ph.D., Burnham Institute for Medical Research
Theodore D. Roth, Roth Capital Partners LLC
Drew Senyei, M.D., Enterprise Partners Venture Capital
Stephen Weber, Ph.D., San Diego State University
Scott N. Wolfe, Latham & Watkins LLP

BIOCOM Board Members-Ex-Officio:

Constance Carroll, Ph.D., San Diego Community College District
Gary Friedman, Esq., The Agouron Institute
David Pyke, Ph.D., University of San Diego
Julie Meier Wright, San Diego Regional EDC
Peter Preuss, The Preuss Foundation
Bob Sullivan, Ph.D., UCSD Rady School of Management